Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

NCT04590664 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Recurrent Glioblastoma

Interventions

DRUG: Verteporfin

Sponsor

Emory University

Collaborators

[object Object]